SOLUBLE ST2 IS AFFECTED BY PULMONARY HYPERTENSION SEVERITY IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY

被引：1
|
作者：
Contractor, Jigar
Deano, Roderick
Szymonifka, Jackie
Zhou, Qing
Beaudoin, Jonathan
Januzzi, James
Singh, Jagmeet
Truong, Quynh
机构：
[1] New York Presbyterian Hosp, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30860-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1266-326
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
  • [1] Relationship of soluble ST2 to pulmonary hypertension severity in patients undergoing cardiac resynchronization therapy
    Beaudoin, Jonathan
    Szymonifka, Jackie
    Lavender, Zachary
    Deano, Roderick C.
    Zhou, Qing
    Januzzi, James L.
    Singh, Jagmeet P.
    Truong, Quynh A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5362 - +
  • [2] The prognostic value of soluble ST2 in patients with pulmonary hypertension
    Geenen, L. W.
    Baggen, V. J. M.
    Boomars, K. A.
    Boersma, E.
    Roos-Hesselink, J. W.
    Van den Bosch, A. E.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1326 - 1327
  • [3] Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
    Boxhammer, Elke
    Mirna, Moritz
    Baz, Laura
    Bacher, Nina
    Topf, Albert
    Sipos, Brigitte
    Franz, Marcus
    Kretzschmar, Daniel
    Hoppe, Uta C.
    Lauten, Alexander
    Lichtenauer, Michael
    LIFE-BASEL, 2022, 12 (03):
  • [4] Soluble ST2 protein as a new biomarker in patients with precapillary pulmonary hypertension
    Banaszkiewicz, Marta
    Pietrasik, Arkadiusz
    Darocha, Szymon
    Pilka, Michal
    Florczyk, Michal
    Dobosiewicz, Anna
    Kedzierski, Piotr
    Pedzich-Placha, Ewa
    Kochman, Janusz
    Opolski, Grzegorz
    Torbicki, Adam
    Kurzyna, Marcin
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (05) : 1442 - 1451
  • [5] The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
    Geenen, Laurie W.
    Baggen, Vivan J. M.
    Kauling, Robert M.
    Koudstaal, Thomas
    Boomars, Karin A.
    Boersma, Eric
    Roos-Hesselink, Jolien W.
    van den Bosch, Annemien E.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [6] Plasma Soluble ST2 Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension
    Zheng, Ya-Guo
    Yang, Tao
    He, Jian-Guo
    Chen, Guo
    Liu, Zhi-Hong
    Xiong, Chang-Ming
    Gu, Qing
    Ni, Xin-Hai
    Zhao, Zhi-Hui
    CLINICAL CARDIOLOGY, 2014, 37 (06) : 365 - 370
  • [7] Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension
    Broch, K. Kaspar
    Lekva, T.
    Ravnestad, H.
    Gullestad, L.
    Andreassen, A. K.
    Ueland, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 390 - 390
  • [8] Effect of Pulmonary Hypertension to the Prognosis of Patients with Cardiac Resynchronization Therapy
    Wang, D. M.
    Han, Y. L.
    Zang, H. Y.
    Yu, H. B.
    Zhang, D. H.
    Wang, S. L.
    Wang, Z. L.
    Jin, Q. M.
    CARDIOLOGY, 2009, 114 : 30 - 30
  • [9] Effect of Pulmonary Hypertension on the Prognosis of Patients With Cardiac Resynchronization Therapy
    Wang, Dongmei
    Han, Yaling
    Zang, Hongyun
    Yu, Haibo
    Wang, Shouli
    Wang, Zulu
    Jing, Quanmin
    CIRCULATION, 2010, 122 (02) : E32 - E32
  • [10] Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension
    Carlomagno, Guido
    Messalli, Giancarlo
    Melillo, Rosa Marina
    Stanziola, Anna Agnese
    Visciano, Carla
    Mercurio, Valentina
    Imbriaco, Massimo
    Ghio, Stefano
    Sofia, Matteo
    Bonaduce, Domenico
    Fazio, Serafino
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1545 - 1547
12345